Skip to main content

Laura Clague

Equibles does not estimate personal net worth.

About Laura Clague

Earlier roles on record: CFO at Travere Therapeutics, Inc. (TVTX) until August 31, 2022. The proxy statement of Travere Therapeutics, Inc. reports total compensation of $1,963,343 for Laura Clague in fiscal 2022, including a base salary of $422,476. Disclosed compensation is on record for 6 fiscal years. Laura Clague has spoken on 10 earnings calls across 1 company, most recently for Travere Therapeutics, Inc. on August 4, 2022. The companies whose calls Laura Clague spoke on are classified in the Healthcare sector.

Laura Clague on recent calls

“For the second quarter of 2022, we reported total revenue of $54.2 million, consisting of approximately $51 million in net product sales and $3.2 million in collaboration revenue from our European collaboration with Vifor Pharma.”
CFO, Travere Therapeutics, Inc. Q2 FY2022 Earnings Call ·
“For the first quarter of 2022, we reported total revenue of $48.5 million, consisting of approximately $46.4 million in net product sales and $2 million in collaboration revenue from our European partnership with Vifor Pharma.”
CFO, Travere Therapeutics, Inc. Q1 FY2022 Earnings Call ·
“For the fourth quarter of 2021, we reported net product sales of $54.6 million from our commercial portfolio compared to $51 million for the same period in 2020.”
CFO, Travere Therapeutics, Inc. Q4 FY2021 Earnings Call ·
“For the third quarter of 2021, we reported net product sales of $54.2 million from our commercial portfolio compared to $51.1 million for the same period in 2020.”
CFO, Travere Therapeutics, Inc. Q3 FY2021 Earnings Call ·
“For the second quarter of 2021, we reported net product sales of $54.6 million from our commercial portfolio, compared to $48.4 million for the same period in 2020.”
CFO, Travere Therapeutics, Inc. Q2 FY2021 Earnings Call ·

Affiliation history

Company network

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2022 Travere Therapeutics, Inc. (TVTX) $422,476 $1,963,343
2021 Travere Therapeutics, Inc. (TVTX) $452,072 $1,934,671
2020 Travere Therapeutics, Inc. (TVTX) $436,801 $1,648,714
2019 Travere Therapeutics, Inc. (TVTX) $419,271 $1,303,582
2018 Travere Therapeutics, Inc. (TVTX) $399,583 $1,860,308
2017 Travere Therapeutics, Inc. (TVTX) $382,467 $1,496,638

Recent activity